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Abstract SWISSspine is a so-called pragmatic trial for
assessment of safety and efficiency of total disc arthroplasty
(TDA). It follows the new health technology assessment
(HTA) principle of ‘‘coverage with evidence development’’.
It is the first mandatory HTA registry of its kind in the
history of Swiss orthopaedic surgery. Its goal is the gener-
ation of evidence for a decision by the Swiss federal office
of health about reimbursement of the concerned technolo-
gies and treatments by the basic health insurance of
Switzerland. During the time between March 2005 and
2008, 427 interventions with implantation of 497 lumbar
total disc arthroplasties have been documented. Data was
collected in a prospective, observational multicenter mode.
The preliminary timeframe for the registry was 3 years and
has already been extended. Data collection happens pre-
and perioperatively, at the 3 months and 1-year follow-up
and annually thereafter. Surgery, implant and follow-up
case report forms are administered by spinal surgeons.
Comorbidity questionnaires, NASS and EQ-5D forms are
completed by the patients. Significant and clinically rele-
vant reduction of low back pain VAS (70.3–29.4 points
preop to 1-year postop, p \ 0.0001) leg pain VAS (55.5–
19.1 points preop to 1-year postop, p \ 0.001), improve-
ment of quality of life (EQ-5D, 0.32–0.73 points preop to 1-
year postop, p \ 0.001) and reduction of pain killer con-
sumption was revealed at the 1-year follow-up. There were
14 (3.9%) complications and 7 (2.0%) revisions within the
same hospitalization reported for monosegmental TDA;
there were 6 (8.6%) complications and 8 (11.4%) revisions
for bisegmental surgery. There were 35 patients (9.8%) with
complications during followup in monosegmental and 9
(12.9%) in bisegmental surgery and 11 (3.1%) revisions
with 1 new hospitalization in monosegmental and 1 (1.4%)
in bisegmental surgery. Regression analysis suggested a
preoperative VAS ‘‘threshold value’’ of about 44 points for
increased likelihood of a minimum clinically relevant back
pain improvement. In a short-term perspective, lumbar
TDA appears as a relatively safe and efficient procedure
concerning pain reduction and improvement of quality of
life. Nevertheless, no prediction about the long-term goals
of TDA can be made yet. The SWISSspine registry proofs
to be an excellent tool for collection of observational data in
a nationwide framework whereby advantages and deficits of
its design must be considered. It can act as a model for
similar projects in other health-care domains.
The online version of the original article can be found under
doi:10.1007/s00586-009-0934-8.
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